About this trial

This study will gauge the efficacy of a home biofeedback treatment device for pelvic floor dysfunction/voiding dysfunction and pelvic pain. Investigators will test the utility of this device as a treatment alternative and/or temporary treatment for a patient's symptoms prior to or perhaps in lieu of their physical therapy appointment.

Eligibility criteria

Qualifiers

Dysfunctional voiding symptoms without chronic pelvic pain.

Chronic pelvic pain with or without dysfunctional voiding symptoms.

Daytime enuresis, nocturnal enuresis, frequency, urgency, dysuria

8 years - 18 years, no one under 8 and no one over 18.

Disqualifiers

Nonverbal or unable to effectively communicate needs and preferences.

Within the voiding dysfunction group, a diagnosis of a congenital GU anomaly (bladder exstrophy, cloacal anomaly, spina bifida, etc.)

No initial medication usage will be excluded; however, if the patient begins a new medication or treatment regimen during the study, the patient will be excluded.

Trial design

Treatments tested in this trial

  • Home Pelvic Floor Trainer

Treatment groups

150 Participants
are divided into 2 treatment groups

Locations

1
University of Colorado Anschutz80011, AuroraColorado, United States

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor